title: Spurious elevation of serum thyrotropin (TSH) after OKT3 administration.
authors: Department of Nephrology, Cliniques Universitaires St-Luc, Brussels, Belgium.
authors: E
authors: E
authors: Goffin
authors: M
authors: M
authors: Lambert
authors: P
authors: P
authors: De Nayer
authors: J M
authors: JM
authors: Saint-Remy
authors: Y
authors: Y
authors: Pirson
authors: C
authors: C
authors: van Ypersele de Strihou
mesh_terms: D000293:Adolescent; D000888:Antibodies, Anti-Idiotypic / Q000097:blood*; D000910:Antibodies, Heterophile / Q000097:blood; D005189:False Positive Reactions; D006084:Graft Rejection / Q000097:blood / Q000628:therapy*; D006801:Humans; D007037:Hypothyroidism / Q000175:diagnosis; D016030:Kidney Transplantation; D008297:Male; D016853:Muromonab-CD3 / Q000276:immunology* / Q000627:therapeutic use; D013972:Thyrotropin / Q000097:blood*
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000910:Antibodies, Heterophile; D016853:Muromonab-CD3; D013972:Thyrotropin